{
    "id": "ab9a16ff-7bca-4445-b6e5-5122e097995c",
    "indications": "Trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults.",
    "contraindications": "Starting dose: 150 mg in divided doses daily. May be increased by 50 mg per day every three to four days. Maximum dose: 400 mg per day in divided doses ( 2 ). Trazodone hydrochloride tablets should be taken shortly after a meal or light snack ( 2 ). Tablets should be swallowed whole or broken in half along the score line, and should not be chewed or crushed ( 2 ). When discontinued, gradual dose reduction is recommended ( 2 ).",
    "warningsAndPrecautions": "Trazodone hydrochloride tablets, USP 50 mg are available for oral administration as, White to off-white, round shape, functionally scored, biconvex tablets, debossed with \"44\" over score line on one side and plain on other side.\n                  Bottles of 100    (NDC 64980-672-01)\n                  Bottles of 500    (NDC 64980-672-50)\n                  Bottles of 1,000 (NDC 64980-672-10)\n                  Trazodone hydrochloride tablets, USP 100 mg are available for oral administration as White to off-white, round shape, functionally scored, biconvex tablets, debossed with \"229\" over score line on one side and plain on other side.\n                  Bottles of 100    (NDC 64980-673-01)\n                  Bottles of 500    (NDC 64980-673-50)\n                  Bottles of 1,000 (NDC 64980-673-10)\n                  Trazodone hydrochloride tablets, USP 150 mg are available for oral administration as White to off-white, oval shape, functionally scored, flat faced beveled tablets having one full bisect and two trisect notches on one side and two trisects on the other side. The full bisected side of the tablet is debossed with '23' on one side of bisect and '0' on other bisect segments on upper side.\n                  Bottles of 100 (NDC 64980-674-01)\n                  Bottles of 500 (NDC 64980-674-50)\n                  Directions for using the correct score when breaking the tablet, please refer to the following:\n                  -For 50 mg, break the score on either the left or right side of the tablet (one-third of a tablet).\n                  \n                  -For 75 mg, break the score down the middle of the tablet (one-half of a tablet).\n                  \n                  -For 100 mg, break the score on either the left or right side of the tablet (two-thirds of a tablet).\n                  \n                  -For 150 mg, use the entire tablet.\n                  \n                  Trazodone hydrochloride tablets, USP 300 mg are available for oral administration as White to off-white, oval shape, functionally scored, flat faced beveled tablets having one full bisect and two trisect notches on one side and two trisects on the other side. The full bisected side of the tablet is debossed with '31' on one side of bisect and '1' on other bisect segments on upper side.\n                  Bottles of 100 (NDC 64980-675-01)\n                  Directions for using the correct score when breaking the tablet, please refer to the following:\n                  -For 100 mg, break the score on either the left or right side of the tablet (one-third of a tablet).\n                  \n                  -For 150 mg, break the score down the middle of the tablet (one-half of a tablet).\n                  \n                  -For 200 mg, break the score on either the left or right side of the tablet (two-thirds of a tablet).\n                  \n                  -For 300 mg, use the entire tablet.\n                  \n                  Store at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Dispense with a child-resistant closure in a tight, light-resistant container.",
    "adverseReactions": "Trazodone hydrochloride tablets are contraindicated in:\n                  \n                     Patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (MAOIs), including MAOIs such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see Warnings and Precautions (5.2), Drug Interactions (7.1)].",
    "ingredients": [
        {
            "name": "TRAZODONE HYDROCHLORIDE",
            "code": "6E8ZO8LRNM"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A",
            "code": "H8AV0SQX4D"
        }
    ],
    "organization": "Rising Pharma Holdings, Inc.",
    "name": "TRAZODONE HYDROCHLORIDE",
    "effectiveTime": "20250402"
}